[ad_1]
Reuters
GILEAD SCIENCES
Scientists in a laboratory at the Gilead Science Center in Laverne, California, where tests for the drug Ramsdevir are performed.
The American pharmaceutical company “Gilead Sciences” announced on Friday that it is moving rapidly with the authorities of the United States to obtain approval to produce and distribute a new drug against Coronavirus.
“We are moving very quickly with the Food and Drug Administration,” said Daniel Uday, CEO of Gilead Sciences, which is working on manufacturing the new test drug, “Ramdesevier,” which is an antivirus.
Oday continued: “The Food and Drug Administration and its Commissioner, Stephen Han, and his team are cooperating wonderfully, and I hope they will act very quickly.”
Odai emphasized that Gilead Sciences is ready to “ensure that this drug is delivered to as many patients as possible and as soon as possible after approval is obtained.”
He continued, “I can assure you that we are all determined to make this drug available to people around the world.”
Odai said the company fully understands its responsibility to change the situation during the outbreak of the new Corona Virus pandemic.
Gilead Sciences previously announced that it intends to donate 1.5 million doses (140,000 10-day treatment courses) of the first deliveries of its medicine as part of the antivirus effort, signaling its intention to work with international partners to expand production. drug potential.
She said she hoped to implement around a million “Ramsdivir” treatment courses through December 2020, to reach this number by several million by 2021.
Studies conducted at the National Institute of Health revealed that “Ramsdevir” can accelerate the recovery of patients with emerging coronavirus infection (COVID-19).
Source: CNN + Reuters
[ad_2]
